Martha Welman, MD in Alexandria, VA - Medicare Pediatrics

Martha Welman, MD is a medicare enrolled "Pediatrics" physician in Alexandria, Virginia. Her current practice location is 3804 Executive Ave, Apt D-1, Alexandria, Virginia. You can reach out to her office (for appointments etc.) via phone at (703) 519-1725.

Martha Welman is licensed to practice in Virginia (license number 0101046898) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1316925977.

Contact Information

	Martha Welman, MD
	3804 Executive Ave, Apt D-1, Alexandria, VA 22305-2118
	(703) 519-1725
	(703) 519-1738

Physician's Profile

Full Name	Martha Welman
Gender	Female
Speciality	Pediatrics
Location	3804 Executive Ave, Alexandria, Virginia
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1316925977
Provider Enumeration Date: 01/04/2006
Last Update Date: 09/11/2007

Medicare PECOS Information:

PECOS PAC ID: 6709863889
Enrollment ID: I20040707000212

Medical Identifiers

Medical identifiers for Martha Welman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316925977	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	0101046898 (Virginia)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Martha Welman allows following entities to bill medicare on her behalf.

Entity Name	Neighborhood Health
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1154674026 PECOS PAC ID: 7517853419 Enrollment ID: O20040707000325

News Archive

UM SOM study leads to FDA approval of Neulasta drug for treatment of radiation injury

As a result of research performed by scientists at the University of Maryland School of Medicine, the U.S. Food and Drug Administration has approved the use of a drug to treat the deleterious effects of radiation exposure following a nuclear incident. The drug, Neulasta, is one of a very small number that have been approved for the treatment of acute radiation injury.

Emergent BioSolutions provides update on TRU-016 Phase 1b study

Emergent BioSolutions Inc. today announced its decision to expand the protocol for its ongoing Phase 1b, single arm, open label study (Protocol 16009) evaluating the safety and efficacy of TRU-016 in combination with rituximab in previously untreated patients with chronic lymphocytic leukemia.

GFCF diet shows no significant benefits on the behavior of children with ASD: Study

A popular belief that specific dietary changes can improve the symptoms of children with autism was not supported by a tightly controlled University of Rochester study, which found that eliminating gluten and casein from the diets of children with autism had no impact on their behavior, sleep or bowel patterns.

Landmark discovery may lead to safe, effective antiviral drugs against COVID-19

The COVID-19 vaccines currently rolling out are providing hope that the spread of the disease can be halted. But infection rates are still high, and for those who contract COVID-19, the search for effective treatments remains important.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Martha Welman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Martha Welman, MD 3804 Executive Ave, Apt D-1, Alexandria, VA 22305-2118 Ph: (703) 519-1725	Martha Welman, MD 3804 Executive Ave, Apt D-1, Alexandria, VA 22305-2118 Ph: (703) 519-1725

News Archive

UM SOM study leads to FDA approval of Neulasta drug for treatment of radiation injury

Emergent BioSolutions provides update on TRU-016 Phase 1b study

GFCF diet shows no significant benefits on the behavior of children with ASD: Study

Landmark discovery may lead to safe, effective antiviral drugs against COVID-19

Pediatrics Doctors in Alexandria, VA

Roman M Kishi, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6303 Little River Tpke, # 300, Alexandria, VA 22312 Phone: 703-914-8989 Fax: 703-914-5494
Emily B Remus, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1451 Belle Haven Rd Ste 110, Alexandria, VA 22307 Phone: 703-765-6093
Dr. Michael Anthony Holliday, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4320 Seminary Rd, Suite 3000, Alexandria, VA 22304 Phone: 703-504-3069 Fax: 703-504-3632
Dr. Nirmala Kharbanda, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6090 Franconia Rd, Suite A, Alexandria, VA 22310 Phone: 703-922-0021 Fax: 703-922-0035
Dr. Clifton Edward Yu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 402 N Union St, Alexandria, VA 22314 Phone: 703-683-0949
Dr. Valeria H Zincke, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4480 King St, Alexandria Health Department, Alexandria, VA 22302 Phone: 703-838-4400 Fax: 703-838-4037
Bethan Clare Fanning, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1451 Belle Haven Rd Ste 110, Alexandria, VA 22307 Phone: 703-765-6093

Martha Welman, MD - Medicare Pediatrics in Alexandria, VA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

UM SOM study leads to FDA approval of Neulasta drug for treatment of radiation injury

Emergent BioSolutions provides update on TRU-016 Phase 1b study

GFCF diet shows no significant benefits on the behavior of children with ASD: Study

Landmark discovery may lead to safe, effective antiviral drugs against COVID-19

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

UM SOM study leads to FDA approval of Neulasta drug for treatment of radiation injury

Emergent BioSolutions provides update on TRU-016 Phase 1b study

GFCF diet shows no significant benefits on the behavior of children with ASD: Study

Landmark discovery may lead to safe, effective antiviral drugs against COVID-19

Pediatrics Doctors in Alexandria, VA